New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. A real-world study found these medications substantially reduced the risk of strokes and heart attacks in type 2 diabetes patients. These findings suggest a potential turning point in diabetes care, highlighting the drugs’ protective effects on the heart.
Related Posts
Top stocks to buy: Stock recommendations for today – check list
Stock market recommendations: According to Mehul Kothari, DVP – Technical Research, Anand Rathi Shares and Stock Brokers, the top stocks to buy today (February 4, […]
Illegally kept secret docs, met Chinese officials: Indian-origin US expert arrested — what we know
An Indian-origin Pentagon contractor and State Department adviser, Ashley Tellis, faces charges for allegedly removing classified Air Force documents. Court records reveal Tellis met extensively […]
Communalism behind attacks on minorities? What B’desh police report says
A police report states that the majority of attacks on minorities in Bangladesh since August 2024 were politically motivated. With 1,769 incidents reported, police confirmed […]